logo
Share SHARE
FONT-SIZE Plus   Neg

Earnings Watch For Jan 29 (DHI, LLY, F, PFE, BSX, BRCM)

Pfizer Inc. (PFE) is due to post its fourth quarter results. The pharmaceutical giant is expected to post earnings of $0.44 per share, lower than the year-ago quarter's $0.50 per share. Also, quarterly revenues are anticipated to decline to $14.37 billion from $16.75 billion in the prior-year quarter. PFE closed Monday at $26.84. (52-wk H/L $27.30/$20.75)

DR Horton Inc. (DHI) is expected to report results for the first quarter before the markets open. The earnings of the homebuilder are expected to increase to $0.14 per share from $0.09 per share reported a year earlier. Quarterly revenues are estimated to grow to $1.10 billion from last year's $884.30 million. On Monday, the stock closed at $21.31. (52-wk H/L $22.79/$13.45)

Drugmaker Eli Lilly & Co. (LLY) is also scheduled to report fourth quarter results before the start of trading. The Indianapolis, Indiana-based company's earnings are expected to decline to $0.78 per share from $0.87 per share reported a year earlier. Quarterly revenues are anticipated to fall to $5.81 billion from last year's $6.05 billion. The company's shares closed Monday's session at $52.64. (52-wk H/L $53.99/$38.30)

Automaker Ford Motor Co. (F) is slated to report results for the fourth quarter. Earnings and revenue for the quarter are expected to be $0.25 per share and $32.94 billion respectively. In the previous year, the Dearborn, Michigan-based company posted earnings of $0.20 per share on revenues of $32.60 billion. The stock closed Monday at $13.78. (52-wk H/L $14.30/$8.82)

Boston Scientific Corp. (BSX) will report its fourth-quarter results today. The company is expected to post earnings of $0.11 per share, up from $0.08 per share reported a year earlier, while quarterly revenues are anticipated to decline to $1.76 billion from last year's $1.85 billion. The company's shares closed Monday's session at $6.86. (52-wk H/L $6.93/$4.79)

Chipmaker Broadcom Corp. (BRCM) is expected to post fourth quarter results after the markets close. The company is expected to earn $0.73 per share, higher than the prior year's $0.68 per share on revenues of $2.07 billion. The company's shares closed Monday's regular trading at $34.06. (52-wk H/L $39.66/$28.60)

Ashland Inc. (ASH), CIT Group Inc. (CIT), Corning Inc. (GLW), Danaher Corp. (DHR), EMC Corporation (EMC), Harley-Davidson, Inc. (HOG), Illinois Tool Works Inc. (ITW), Kulicke and Soffa Industries, Inc. (KLIC), Lexmark International Inc. (LXK), Nucor Corporation (NUE), Peabody Energy Corp. (BTU), Tupperware Brands Corporation (TUP), United States Steel Corp. (X), Tyco International Ltd. (TYC), Valero Energy Corporation (VLO), ACE Limited (ACE), Arthur J Gallagher & Co. (AJG), Boston Properties Inc. (BXP), Dolby Laboratories, Inc. (DLB), Freescale Semiconductor, Ltd. (FSL), Hutchinson Technology Inc. (HTCH), Manhattan Associates, Inc. (MANH), PAREXEL International Corporation (PRXL), Spansion Inc. (CODE), Unisys Corporation (UIS) and Websense, Inc. (WBSN) are also slated to report their results.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Fast food giant McDonald's on Wednesday announced its global growth plan, targeting sales growth of 3-5% beginning in 2019. The company also highlighted its vision for new restaurants relying on technology such as self-ordering kiosks, curbside pick ups and partnerships with delivery services. At... Canadian drug-maker Valeant Pharmaceuticals International, Inc. on Tuesday reported a loss for the fourth quarter that widened from last year on a double-digit decline in revenues. However, both revenue and adjusted earnings beat analysts' estimates. Valeant also said it plans to relaunch its sexual dysfunction drug Addyi in the U.S. Electronics retailer Best Buy Co., Inc. Wednesday issued guidance for first-quarter adjusted earnings and revenues, below market estimates. Comparable sales are expected to be weak. For fiscal 2018, the company projects higher revenues and operating income. In its fourth quarter, the company posted higher profit, above market view, while revenues missed estimates with lower comparable sales.
comments powered by Disqus
Follow RTT